Abstract:Non-alcoholic fatty liver disease (NAFLD) is recognized as the most frequent classification of liver disease around the globe. Along with the sequencing technologies, gut microbiota has been regarded as a vital factor for the maintenance of human and animal health and the mediation of multiple diseases. The modulation of gut microbiota as a mechanism affecting the pathogenesis of NAFLD is becoming a growing area of concern. Recent advances in the communication between gut and hepatic tissue pave novel ways to better explain the molecular mechanisms regarding the pathological physiology of NAFLD. In this review, we recapitulate the current knowledge of the mechanisms correlated with the development and progression of NAFLD regulated by the gut microbiome and gut–liver axis, which may provide crucial therapeutic strategies for NAFLD. These mechanisms predominantly involve: (1) the alteration in gut microbiome profile; (2) the effects of components and metabolites from gut bacteria (e.g., lipopolysaccharides (LPS), trimethylamine-N-oxide (TMAO), and N,N,N-trimethyl-5-aminovaleric acid (TMAVA)); and (3) the impairment of intestinal barrier function and bile acid homeostasis. In particular, the prevention and therapy of NAFLD assisted by nutritional strategies are highlighted, including probiotics, functional oligosaccharides, dietary fibers, ω-3 polyunsaturated fatty acids, functional amino acids (L-tryptophan and L-glutamine), carotenoids, and polyphenols, based on the targets excavated from the gut–liver axis.

New Achievements in Researches on Non-alcoholic Liver Disease

Research Progress on the Mechanism of Traditional Chinese Medicine in the Treatment of Non-Alcoholic Fatty Liver Disease Based on Oxidative Stress

Non-alcoholic Fatty Liver Disease: the Problems We Are Facing.

[Research Advances in Diagnosis of Non-Alcoholic Fatty Liver Disease].

Recent Progress of Proteomics in Nonalcoholic Fatty Liver Disease*

Research advances in non-alcoholic fatty liver disease: a review of current status and prospect

Current status of research on nonalcoholic fatty liver disease in China

Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine

Current insights in molecular characterization of non-alcoholic fatty liver disease and treatment

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)

Progress in Non-invasive Diagnosis and Assessment of Non-alcoholic Fatty Liver Disease

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease

Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment

Relevance of Nonalcoholic Fatty Liver Disease and Obesity and their Treatment Advances

The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement

Current Innovations in Nutraceuticals and Functional Foods for Intervention of Non-Alcoholic Fatty Liver Disease

Research progress on the regulation of cholesterol metabolism in the treatment of nonalcoholic fatty liver disease

Emerging novel targets for nonalcoholic fatty liver disease treatment: Evidence from recent basic studies

Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease

Research Advances in Extrahepatic Diseases Associated with Nonalcoholic Fatty Liver Disease

NAFLD and NASH: etiology, targets and emerging therapies